(Q27009190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

27 September 2020

Molecular biology of high-grade gliomas: what should the clinician know? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

chromosomal deletion syndrome

2 March 2020

main subject

1 reference

27 September 2020

1 reference

27 September 2020

1 reference

27 September 2020

restriction/modification DNA-methylase

1 reference

tumor suppressor proteins

28 September 2019

1 reference

18 December 2019

1 reference

27 September 2020

0 references

isocitrate dehydrogenase

1 reference

PubMed publication ID

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Silvia Hofer

series ordinal

1

2 references

Crossref

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Elisabeth Rushing

series ordinal

2

2 references

Crossref

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Christine Marosi

series ordinal

4

2 references

Crossref

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

11 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

Chinese Journal of Cancer

2 March 2020

1 January 2014

1 reference

27 September 2020

10 references

3 April 2019

25 April 2019

20 June 2019

30 June 2019

14 September 2019

28 September 2019

18 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

27 September 2020

33

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

4-7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

2 March 2020

copyright license

8 references

3 April 2019

25 April 2019

20 June 2019

30 June 2019

14 September 2019

28 September 2019

18 December 2019

on focus list of Wikimedia project

27 September 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

The 2007 WHO classification of tumours of the central nervous system

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Epithelioid GBMs show a high percentage of BRAF V600E mutation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Circulating biomarkers of CNS tumors: an update.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Targeted therapy for BRAFV600E malignant astrocytoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Molecular markers in gliomas: impact for the clinician

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905084

28 November 2018

Identifiers

DOI

10.5732/CJC.013.10218

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

24325789

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325789%20AND%20SRC:MED&resulttype=core&format=json